Toxic genomic
Toxic genomic In this report, toxic genomic is well-defined as the application of genomic technologies (for example, genetics, genome sequence analysis, gene expression profiling, proteomics, metabolomics, and related approaches) to study the adverse effects of environmental and pharmaceutical chemicals on human health and the environment. Researchers, regulators, and the public all desire efficient and correct methods to assess the toxicologic effects of chemical, physical, and biologic agents on living systems. Yet, no single approach happens to analyse toxicologic responses, a tough task given the complexity of human and animal physiology and individual variations. The genomic information and novel technologies that have appeared in the post-genomic time promise to inform the thoughtful of many risks as well as enlighten current approaches and lead to novel predictive approaches for studying disease risk.
Related Conference of Toxic genomic
20th International Conference on Environmental Toxicology and Ecological Risk Assessment
7th International Conference on Global Toxicology and Risk Assessment
22nd International Conference on Clinical Toxicology and Pharmacology
5th International Conference on Clinical Pharmacology and Toxicology
Toxic genomic Conference Speakers
Recommended Sessions
- Analytical Toxicology
- Aquatic Toxicology
- Behavior Toxicology
- Chemical Toxicology
- Clinical Pharmacological
- Ecological Risk Assessment
- Experimental and Toxicologic Pathology
- Human Health Toxicology
- Immuno Toxicology
- In Vitro Toxicology
- Medical Development and Safety Testing
- Microbial Toxicology
- Nano toxicology
- Pharmacology
- Toxic genomic
- Toxicology
Related Journals
Are you interested in
- Analytical Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Aquatic Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Behavior toxicology - clinicalpharmacology2023 (Spain)
- Behavior Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Bio-availability - clinicalpharmacology2023 (Spain)
- Bio-equivalence - clinicalpharmacology2023 (Spain)
- Biochemical Pharmacology - clinicalpharmacology2023 (Spain)
- Biologic drugs - clinicalpharmacology2023 (Spain)
- Chemical Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Clinical and medical pharmacology - clinicalpharmacology2023 (Spain)
- Clinical Pharmacological - GLOBAL TOXICOLOGY 2023 (Portugal)
- Drug discovery and Drug development - clinicalpharmacology2023 (Spain)
- Drug Safety - clinicalpharmacology2023 (Spain)
- Ecological Risk Assessment - GLOBAL TOXICOLOGY 2023 (Portugal)
- Environmental Toxicology - clinicalpharmacology2023 (Spain)
- Experimental and Toxicologic Pathology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Genotoxicity - clinicalpharmacology2023 (Spain)
- Human Health Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Immuno Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- In Vitro Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Medical Development and Safety Testing - GLOBAL TOXICOLOGY 2023 (Portugal)
- Microbial Toxicology - clinicalpharmacology2023 (Spain)
- Microbial Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Molecular Pharmacology - clinicalpharmacology2023 (Spain)
- Nano toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Nanomedicine and Nanotechnology - clinicalpharmacology2023 (Spain)
- Pharmaceutical biotechnology - clinicalpharmacology2023 (Spain)
- Pharmacodynamics - clinicalpharmacology2023 (Spain)
- Pharmacogenomics - clinicalpharmacology2023 (Spain)
- Pharmacokinetics - clinicalpharmacology2023 (Spain)
- Pharmacology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Pharmacology and Toxicology - clinicalpharmacology2023 (Spain)
- Pharmacovigilance - clinicalpharmacology2023 (Spain)
- Route of administration - clinicalpharmacology2023 (Spain)
- Toxic genomic - GLOBAL TOXICOLOGY 2023 (Portugal)
- Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)